Global Medical Device Adhesive Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Medical Device Adhesive Market Size

• The global medical device adhesive market was valued at USD 8.53 billion in 2024 and is expected to reach USD 16.91 billion by 2032
• During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 7.9%, primarily driven by growing demand for minimally invasive procedures
• This growth is driven by factors such as the unique requirements of MIS necessitate adhesives that offer strong bonding, biocompatibility, and ease of removal. This demand drives innovation in adhesive formulations tailored for such applications

Medical device adhesive market Analysis

• Rising use of disposable medical devices, drives adhesive demand, particularly for syringes, diagnostic tools, and IV systems requiring safe, sterile bonding.
• Increased preference for minimally invasive surgeries fuels demand for high-performance, skin-friendly adhesives in wearable sensors, patches, and wound care devices.
• Manufacturers focus on developing biocompatible and eco-friendly adhesives to meet regulatory demands and patient safety, spurring innovation in water-based and solvent-free formulations.

Report Scope and Medical device adhesive market Segmentation   

Medical device adhesive market Trends

“Shift Toward Biocompatible and Skin-Friendly Adhesive Formulations”

• There’s growing adoption of wearable healthcare devices such as glucose monitors, ECG patches, and insulin pumps. These require adhesives that stay on the skin for long durations without causing irritation. This has driven innovation in gentler, more breathable adhesive technologies.
• Companies like 3M and Henkel have developed low-trauma adhesives tailored for sensitive skin, particularly for pediatric, elderly, or long-term care patients. 
  • For instance, 3M's Extended Wear Medical Tapes, such as the 4576 and 4578, are designed for extended wear applications, offering secure adhesion to the skin for up to 21 days. These tapes are flexible, conformable, and minimize skin irritation, making them suitable for various medical and retail devices.

https://www.3mindia.in/3M/en_IN/p/d/v101544000/  

• There is growing interest in adhesives derived from bio-based raw materials and those free from irritants like latex or acrylates. This not only supports sustainability goals but also reduces the risk of skin sensitization.
• As patient comfort and skin integrity become central to device performance and patient compliance, the demand for biocompatible adhesives is reshaping R&D and product development in the medical adhesive sector, positioning skin-friendly solutions as a competitive advantage.

Medical device adhesive market Dynamics

Driver

“Growing Demand for Minimally Invasive Procedures”

• Patients and healthcare providers increasingly favor MIS due to benefits like reduced recovery times, minimal scarring, and lower infection risks. These procedures often require specialized adhesives to secure devices such as catheters and endoscopes effectively.
• The unique requirements of MIS necessitate adhesives that offer strong bonding, biocompatibility, and ease of removal. This demand drives innovation in adhesive formulations tailored for such applications.
• The growth of wearable health monitors and implantable devices, which often involve minimally invasive placement, further amplifies the need for advanced adhesive solutions that can maintain performance over extended periods.

For instance,

• 3M's Tegaderm dressings are indeed widely used to cover insertion sites for IV catheters and central lines. These dressings are specifically designed for this purpose, offering features like securement, moisture management, and infection prevention, which are crucial for maintaining a clean and secure insertion site.

https://www.3m.com/3M/en_LB/p/d/b00035626/     

• In conclusion, as the healthcare industry continues to prioritize patient comfort and procedural efficiency, the demand for specialized adhesives designed for MIS applications is expected to rise, fostering market growth.

Opportunity

“Expansion of Home Healthcare and Point-of-Care (PoC) Diagnostics”

• An aging global population and increasing prevalence of chronic conditions such as diabetes, cardiovascular disease, and respiratory disorders are boosting demand for home-based care. Medical adhesives are critical for securing sensors, patches, and other diagnostic components used outside clinical settings.
• Devices like lateral flow assays (e.g., COVID-19 self-tests), glucose meters, and rapid antigen tests require precise and reliable adhesive applications to bond layers of films, membranes, and housings. For instance, Scapa Healthcare and Avery Dennison supply adhesives specifically designed for high-volume diagnostic consumables.
• Home-use diagnostics must be simple to operate and affordable. Adhesives play a key role in device design by enabling streamlined assembly and durable performance without costly mechanical fasteners—particularly in single-use or disposable formats.
• The growing global emphasis on decentralized healthcare and PoC diagnostics creates a sustained and scalable opportunity for medical device adhesive manufacturers. Tailoring solutions for ease of use, sterility, and cost-efficiency will be critical for long-term growth in this segment.

Restraint/Challenge

“Regulatory Compliance and Approval Complexity”

• Medical device adhesives must meet stringent and often differing regulatory standards in the U.S. (FDA), Europe (MDR), and Asia (e.g., PMDA in Japan). This creates complexity for manufacturers aiming for global distribution.
• Adhesives used on or in the human body must undergo ISO 10993 testing to ensure they do not cause cytotoxicity, irritation, or sensitization. This testing is time-consuming and expensive, increasing development costs and time to market.
• Regulations evolve, such as the shift from MDD to MDR in the EU. Companies must constantly adapt formulations and documentation, even for long-established products. This strains resources and delays product launches.
• Navigating regulatory compliance remains a significant hurdle for the global medical device adhesive industry, affecting cost, innovation speed, and global market access.

Medical device adhesive market Scope

The market is segmented on the basis of resin type and application.

Medical device adhesive market Regional Analysis

“North America is the Dominant Region in the Medical device adhesive market”

• North America dominates the medical device adhesive market, due to presence of major key players is a major factor responsible for the growth of medical device adhesive market.

• The U.S. holds a significant share due to rising research and development activities to innovate with pharmaceutical drugs and equipment will further create lucrative growth opportunities for the medical device adhesive market.

“Asia-Pacific is Projected to Register the Highest Growth Rate”

• Asia-Pacific region is expected to witness the highest growth rate in the medical device adhesive market, driven by rising medical tourism is indirectly inducing growth of medical device adhesive market in this region

• China is expected to lead the growth due to easy availability of low-cost labour and abundant raw materials will further grab many eyeballs of the manufacturers.

Medical device adhesive market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

The Major Market Leaders Operating in the Market Are:

• Medtronic (Ireland)
• 3M (U.S.)
• Baxter (U.S.)
• Carestream Health (U.S.)
• Henkel Adhesive Technologies India Private Limited (India)
• Dymax (U.S.)
• Dr. Hönle AG (Germany)
• H.B. Fuller Company (U.S.)
• Master Bond Inc. (U.S.)
• Permabond LLC (U.K.)
• EPOXY TECHNOLOGY, INC. (U.S.)
• Novachem Corporation Ltd (Canada)
• Incure Inc. (U.S.)
• Panacol-Elosol GmbH (Germany)
• Stryker (U.S.)
• Dentsply Sirona (U.S.)
• Bostik (France)
• Avery Dennison Corporation (U.S.)
• Dow (U.S.)
• Ashland (U.S.)

Latest Developments in Global Medical device adhesive market

• In November 2022, Flexcon unveiled four new products aimed at the healthcare and pharmaceutical sectors.

• In October 2022, DuPont launched a Chinese-language regional website (liveo.dupont.cn) dedicated to its DuPont Liveo Healthcare Solutions brand. This initiative is designed to support the growing demand in China for premium, high-performance healthcare solutions.

SKU-14959